Modulation of programmed death of the peripheral blood lymphocytes under chronic virus infection

Tsitologiya

Volumn 49, Issue 1, 2007, Pages 26-31

  Zhukova, O B ^a   Ryazantseva, N V ^a   Novitskiy, V V ^a   Radzivil, T T ^a   Litvinova, L S ^a   Chasovskikh, N Yu ^a  

^a SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Apoptosis; Chronic virus infection; Fas receptor; Lymphocyte; Mitochondrial membrane potential; Modulation; TNF receptor

Indexed keywords

DEXAMETHASONE; ETOPOSIDE; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CHRONIC DISEASE; COMPARATIVE STUDY; HEPATITIS B; HEPATITIS C; HUMAN; LYMPHOCYTE; METABOLISM; MITOCHONDRION; MONONUCLEAR CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TICK BORNE ENCEPHALITIS;

ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; CHRONIC DISEASE; DEXAMETHASONE; ENCEPHALITIS, TICK-BORNE; ETOPOSIDE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MEMBRANE POTENTIALS; MITOCHONDRIA; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 34247273015     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Russian source
10. Russian source
11. Russian source
12. Russian source
13. Russian source
14. Russian source
15. Russian source
16. Russian source
17. Russian source
18. Russian source
19. Russian source
20. Russian source
21. Ahn J. Y., Jung E. Y., Kwun H. J. 2002. Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J. Gen. Virol. 83: 2765-2772.
22. Chang Z. S., Zeng L. B., Chang C. S., Qing W. W. 2003. Aggregate formation of hepatitis B virus X protein affects cell cycle and apoptosis. World J. Gastroenterol. 9: 1521-1524.
23. 2 arrest in response to topoisomerase II inhibitors. The role of p53. Cancer Res. 63: 4074-4081.
24. Dbaibo G., Hannun J. 1998. Molecule of the month cytokine response modifer: a strategically deployed viral weapon. Clin. Immumol. Immunopathol. 86: 134-140.
25. Ehrmann J., Jr., Galuszkova D., Ehrmann J., Krc I., Jezdinska V., Vojtesek B., Murray P. G., Kolao Z. 2000. Appptosis-related proteins Bcl-2, Bax, Fas, Fas-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection. Pathol. Oncol. Res. 6: 130-135.
26. Hay S., Kannourakis G. 2002. A time to kill: viral manipulation of the cell death program. J. General Virol. 83: 1547-1564.
27. Kountouras J., Zavos C., Chatzopoulos D. 2003. Apoptosis in hepatitis C. J. Virol. Hepatol. 10: 335-342.
28. Otsuka M., Kato N., Taniguchi H., Yoshida H., Goto T., Shiratory Y., Omata M. 2002. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. Virology. 296: 84-93.
29. Suda T., Nagata S. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179: 873-877.
30. Takamatsu M., Fujita T., Hotta H. 2001. Suppression of serum starvation-induced apoptosis by hepatitis C virus core protein. Kobe J. Med. Sci. 112: 97-112.
31. Tanaka M., Itai T., Adachi M., Nagata S. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4: 31-36.
32. Van Engeland M., Nieland L. J. W., Ramaekers F. C. S. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 31: 1-9.
33. Wuchter C., Ruppert V., Schrappe M. 2002. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood. 99: 4109-4115.